Showing results (91-100 of 5,291) with videos related to
Sort By:
Pageof 530
Cancer Research|October 1, 1984
Potent activation of mouse macrophages by recombinant interferon-gammaL Varesio, E Blasi, G B Thurman, et al.Cancer Research|September 1, 1986
Immunomodulatory and therapeutic properties of bestatin in miceJ E Talmadge, B F Lenz, R Pennington, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
T-cell reconstitution by molecular, phenotypic, and functional analysis in the thymus, bone marrow, spleen, and blood following split-dose polychemotherapy and therapeutic activity for metastatic breast cancer in miceJ E Talmadge, J D Jackson, L Kelsey, et al.Drugs Under Experimental and Clinical Research|January 1, 1987
Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2J E Talmadge, P L Black, H Tribble, et al.Cancer Research|November 24, 2001
Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell responseP Parajuli, V Pisarev, J Sublet, et al.International Journal of Immunopharmacology|November 1, 1992
Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC]P L Black, D Hartmann, R Pennington, et al.Blood|May 1, 1989
Myelostimulatory activity of recombinant human interleukin-2 in miceJ E Talmadge, M Schneider, J Keller, et al.Cancer Research|March 1, 1986
Dissociation of therapeutic and toxic effects of polyinosinic-polycytidylic acid admixed with poly-L-lysine and solubilized with carboxymethyl cellulose in tumor-bearing miceD Hartmann, J S Adams, A K Meeker, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Expression of interleukin-10 in isolated CD8+ T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunctionM L Varney, K Ino, A G Ageitos, et al.Experimental Hematology|May 17, 2000
Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patientsR K Singh, M L Varney, K Ino, et al.Pageof 530